Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells

Erin R. Scheidemann, Diane M. Demas, Chunyan Hou, Junfeng Ma, Wei He, Gaurav Sharma, Eric Schultz, Katherine N. Weilbaecher, Ayesha N. Shajahan-Haq

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences